A A MENU

PBPK Modeling and quantitative in vitro-in vivo extrapolations

October 3, 2019 - October 4, 2019

Physiologically based pharmacokinetic (PBPK) modelling plays a crucial role in next generation (non-animal) risk evaluations to inform the design of in vitro studies and to convert the data obtained with in vitro models into human dose−response or potency information. The goal of the course is to acquaint participants with setting up PBPK models based on non-animal input parameters and to subsequently use these models to extrapolate in vitro bioassay data to human dose-response or potency information.

The course consists of:

– Lectures that cover the basic principles of PBPK model-development and the application of PBPK modelling in different fields (e.g. safety evaluations of pharmaceuticals and industrial chemicals, development of alternatives to animal testing).

– Hands-on experience focussing on how to derive adequate chemical-specific input parameters.

– Hands-on experience with developing PBPK models in Berkeley Madonna software.

– Hands-on experience with developing PBPK models with Simcyp’s Population-based Simulator.

– Use of the models to extrapolate in vitro bioassay results to human dose-response or potency information

The training will only take place if minimum of 8 participants is reached.

« All Events

Venue

RIKILT Wageningen University and Research
Akkermaalsbos 2 6708
Wageningen, 6708 Netherlands
Website:
https://www.wur.nl/nl/Onderzoek-Resultaten/Onderzoeksinstituten/RIKILT.htm

Organizer

ALTERTOX
Website:
http://academy.altertox.be/